Navidea Biopharmaceuticals Announces Reverse Stock Split

Apr 19, 2019

Navidea Biopharmaceuticals Receives FDA Feedback Regarding Rheumatoid Arthritis Clinical Trial Design and Provides Business Updates

Apr 8, 2019

Navidea Biopharmaceuticals Data to be Presented at Society of Nuclear Medicine and Molecular Imaging Annual Meeting

Apr 2, 2019

Navidea Biopharmaceuticals Announces Stock Purchase Agreement; Other Business Updates

Mar 22, 2019

Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 7, 2019

Navidea Biopharmaceuticals Schedules Fourth Quarter 2018 Earnings Conference Call and Business Update

Feb 28, 2019

Navidea Biopharmaceuticals Announces Extension of NYSE American Listing

Feb 1, 2019

Navidea Biopharmaceuticals Announces Decision by Ohio Supreme Court

Jan 24, 2019

Navidea Biopharmaceuticals Announces Patent Extension for Lymphoseek®

Dec 7, 2018

Navidea Biopharmaceuticals Appoints Adam Cutler to Board of Directors

Nov 29, 2018